At a glance
- Originator sigma-tau SpA
- Class
- Mechanism of Action Carnitine O-palmitoyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 25 Aug 2003 No development reported - Preclinical for Type-2 diabetes mellitus in Italy (unspecified route)
- 12 Dec 2001 Preclinical development for Type-2 diabetes mellitus in Italy (Unknown route)